RNA
$31.82
Revenue | $2.34Mn |
Net Profits | $-80.4Mn |
Net Profit Margins | -3441.7% |
Avidity Biosciences Inc’s revenue fell -17.1% since last year same period to $2.34Mn in the Q3 2024. On a quarterly growth basis, Avidity Biosciences Inc has generated 14.23% jump in its revenue since last 3-months.
Avidity Biosciences Inc’s net profit fell -53.55% since last year same period to $-80.4Mn in the Q3 2024. On a quarterly growth basis, Avidity Biosciences Inc has generated -13.57% fall in its net profits since last 3-months.
Avidity Biosciences Inc’s net profit margin fell -85.24% since last year same period to -3441.7% in the Q3 2024. On a quarterly growth basis, Avidity Biosciences Inc has generated 0.58% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.71 |
EPS Estimate Current Year | -0.71 |
Avidity Biosciences Inc’s earning per share (EPS) estimates for the current quarter stand at -0.71 - a 10.13% jump from last quarter’s estimates.
Avidity Biosciences Inc’s earning per share (EPS) estimates for the current year stand at -0.71.
Earning Per Share (EPS) | -0.65 |
Avidity Biosciences Inc’s earning per share (EPS) jumped 8.45% since last year same period to -0.65 in the Q3 2024. This indicates that the Avidity Biosciences Inc has generated 8.45% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-05-09 | -0.78 | -0.79 | -1.28% |
2024-09-30 | -0.71 | -0.65 | 8.45% |
2024-08-09 | -0.79 | -0.65 | 17.72% |